Abstract: Based on all studies that investigated both leptin concentration (LC) and body mass index (BMI), LC was positively correlated with the BMI. No studies established reference ranges according to the Clinical and Laboratory Standards Institute (CLSI) in healthy postmenopausal women (PW), and there was a wide variation in LC values. These differences suggest that caution should be used in the interpretation and comparison between studies.
Introduction
Leptin, a hormone primarily secreted by adipose tissue, plays a fundamental role in regulating energy balance and hunger. In postmenopausal women, fluctuations in leptin levels are clinically significant, as they are linked to obesity, insulin resistance, and increased risks for certain cancers, such as breast and ovarian cancer. Despite its clinical importance, the medical community lacks a universally accepted "normal" reference range for leptin in this demographic. This meta-analysis aims to synthesize existing data to determine a reliable reference range and identify how variables like BMI, age, and Hormone Replacement Therapy (HRT) influence these values.
Methodology and Study Selection
The researchers conducted a systematic search of major databases, including Medline, Embase, and Cochrane, for English-language studies published between 1994 and 2012. To synthesize the data, they employed Fisher’s $r$-to-$Z$ transformation to normalize correlation coefficients across different studies. Both fixed and random effects models were used to account for variations, while heterogeneity was assessed using the Q-statistic.
The final analysis included a pooled population of 3,093 healthy postmenopausal women derived from 27 individual studies, including cross-sectional and cohort designs. Most studies utilized Radioimmunoassay (RIA) for LC measurement.
Key Insights
- The Importance of Standardization: Statistical noise in the data decreased significantly when the analysis was restricted to studies that collected samples in the morning from fasting subjects. This highlights leptin's sensitivity to circadian rhythms and caloric intake.
- BMI as the Primary Driver: Leptin levels are predominantly a reflection of total adipose mass. The analysis suggests that LC explains approximately 21% of the variation in BMI.
- HRT and Age: Interestingly, HRT did not significantly alter leptin levels in most studies, suggesting leptin regulation is somewhat independent of the estrogen/progesterone axis in postmenopausal women. Similarly, age within the postmenopausal bracket had a negligible effect compared to BMI.
Key Results
The meta-analysis confirmed a consistent positive correlation between LC and BMI. The combined correlation coefficient ($r$) was 0.51 (95% CI: 0.46–0.54). When the analysis was limited to morning fasting samples, this correlation strengthened to 0.54, with improved statistical consistency.
Despite this correlation, the reported "normal" values for leptin varied extremely, ranging from 1.0 ng/mL to 80.8 ng/mL across different studies. This variance is largely attributed to the lack of standardized clinical protocols.
Conclusion
The primary challenge in establishing a clinical reference range for leptin is methodological inconsistency. Variations in assay types (RIA vs. ELISA) and sampling conditions make cross-study comparisons difficult. Future research must adhere to CLSI protocols—standardizing sampling time and assay kits—before leptin can be reliably used as a clinical biomarker for postmenopausal health.
Summary updated